We have several promising therapeutic drugs currently in development
Developing New Platforms
Our novel approach suggests a new paradigm in the treatment of aggressive cancers that either recur in the same location or metastasize to distal sites. In both cases, tumors of this type typically are resistant to conventional therapeutic agents. Any new drug that adds to the arsenal of treatment options that is well tolerated and has a low-toxicity potential therapeutic use could have major implications not only for aggressive cancers such as PDAC, but possibly the large number of patients with lower-risk disease.
COARE Biotechnology’s novel platform for targeting metastases is an untapped medical need with enormous potential. Most conventional models of drug development focus on killing the primary tumor. Our focus is on the critical interplay between elimination of the primary tumor and the later development of metastasis, which is responsible for eventual death of most patients.